ExpreS2ion Biotech Holding AB
EXPRS2 | ST
Overview
Corporate Details
- ISIN(s):
- SE0008348262 (+4 more)
- LEI:
- 549300FJK50P1ORYJC45
- Country:
- Sweden
- Address:
- C/O Mindpark, 252 25 Helsingborg
- Website:
- https://www.expres2ionbio.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
ExpreS2ion Biotech Holding AB develops protein production technologies for vaccines and diagnostics. They focus on advancing global health.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for ExpreS2ion Biotech Holding AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all ExpreS2ion Biotech Holding AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ExpreS2ion Biotech Holding AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Novo Nordisk | Denmark | NOVO | |
|
NRGene Technologies Ltd. | Israel | NRGN | |
|
NUFORMIX PLC | United Kingdom | NFX | |
|
Nykode Therapeutics ASA | Norway | NYKD | |
|
Oculis Holding AG | Switzerland | OCS | |
|
ONCODESIGN | France | ALONC | |
|
Oncodesign Precision Medicine S.A | France | ALOPM | |
|
Oncoinvent ASA | Norway | OCIN | |
|
Oncopeptides | Sweden | ONCO | |
|
Onxeo | France | ALONX |